Abstract A bacterial pinoresinol/lariciresinol reductase (PLR) homolog named NrPinZ was obtained from a Novosphingobium rhizosphaerae sp. LY bacterial strain, with NrPinZ being part of its 5‐step biochemical system catabolizing pinoresinol into coniferyl aldehyde and vanillin. Recombinant NrPinZ reduces racemic 8–8′ furanofuran lignans (±) ‐pinoresinols, medioresinols, and syringaresinols with similar overall catalytic efficiencies. In those reductions, only one of the two furan ring systems is reduced. Two other bacterial PLR homologs, NaPinZ and SlPinZ, from N. aromaticivorans F199 and Sphingobium lignivorans SYK‐6, respectively, had comparable substrate versatilities and catalytic efficacies. Plant PLR homologs, by comparison, are either enantiospecific, enantioselective, or variants thereof, being able to reduce either one or both furan rings. For example, a recombinant enantioselective PLR (PLRTp2) from western red cedar (Thuja plicata) preferentially reduces both (+) ‐pinoresinol furan rings to afford (−) ‐secoisolariciresinol. BoltZ‐2 modeling of NrPinZ and PLRTp2, together with substrate docking of (+) ‐ and (−) ‐pinoresinols, medioresinols, and syringaresinols, was very instructive. The NrPinZ active site P1/P2 sub‐pockets allow for both racemic forms to be catabolized. Conversely, the smaller P1 pocket in PLRTp2 preferentially positions (+) ‐pinoresinol for downstream metabolism into (−) ‐secoisolariciresinol, thereby providing a biochemical explanation for the different stereochemical outcomes. NrPinZ, NaPinZ, and SlPinZ, catalyzing substrate versatile catabolism of both racemic forms, may have important ramifications for gymnosperm and angiosperm lignin and lignan biodegradation, including its evolutionary significance and potential in enzyme engineering.
Smith et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: